EUVIMEDEUVIMED entdecken
Crossref

Antifungal activity of bamemacrolactine C against Talaromyces marneffei and its possible mechanisms of action

Cuiping Jiang, Guangfu Feng, Zhou Wang, Kai Liu, Xinjian Qu, Yonghong Liu, Xiangxi Yi, Chenghai Gao

Journal of Applied Microbiology · 2024

DOI: 10.1093/jambio/lxae297 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Applied Microbiology, 2024. Verfasst von Cuiping Jiang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Marine Drugs, Faculty of Pharmacy, Guangxi University of Chinese Medicine, No.13 Wuhe Road, Nanning 530200, China. Hauptthemen laut MEDLINE: Talaromyces, Antifungal Agents, Microbial Sensitivity Tests. Die Arbeit nennt 59 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Program of Science and Technology Department of Guangxi, Joint Fund of NSFC-Guangxi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The present study aims to investigate the in vitro antifungal activity and mechanism of action of bamemacrolactine C (BAC), a new 24-membered macrolide compound, against Talaromyces marneffei. Methods and results The test drug BAC initially demonstrated antifungal activity through a paper disk diffusion assay, followed by determination of the minimum inhibitory concentration value of 35.29 μg ml−1 using microdilution. The association study revealed that combination therapy exhibited additive effects (0.5 < FICI < 1.0) when combined BAC with either amphotericin B or fluconazole. A time-growth assay confirmed that treatment with 35.29 μg ml−1 of BAC completely inhibited the growth of T. marneffei and exhibited antifungal effects. Micromorphological analysis using scanning electron microscopy and transmission electron microscopy photomicrographs revealed that BAC treatment induced morphological damage in fungal cells compared to the control group. Transmembrane protein assays showed a significant reduction in the levels of Na+/K+-ATPase (P < .05) and Ca2+-ATPase (P < .01) compared to the control group. Intracellular enzyme assays demonstrated that BAC treatment significantly decreased ATP, malate dehydrogenase, and succinate dehydrogenase content (P < .01). The combination of proteomics and parallel reaction monitoring (PRM) verification indicated that BAC exhibits an antifungal mechanism against T. marneffei by downregulating ATP citric acid lyase (ACLY) levels , potentially affecting the tricarboxylic acid (TCA) cycle. Besides, the binding model of BAC and the ACLY also shows a good docking score.

Conclusions

The findings suggest that BAC exhibits antifungal activity against T. marneffei, elucidating its multifaceted mechanism of action involving disruption of cell membranes’ integrity and inhibition of intracellular enzyme activities, in which the modulation of ACLY in the TCA cycle may play an important role.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TalaromycesAntifungal AgentsMicrobial Sensitivity TestsMacrolides

Stichwörter der Autor:innen

Talaromyces marneffei24-membered macrolideantifungal activityantifungal mechanismbamemacrolactine C

Substanzen

Antifungal AgentsMacrolides

Autor:innen und Institutionen

  • Institute of Marine Drugs, Faculty of Pharmacy, Guangxi University of Chinese Medicine, No.13 Wuhe Road, Nanning 530200, China.
  • Guangxi Key Laboratory of Marine Drugs, Institute of Marine Drugs, Faculty of Pharmacy, Guangxi University of Chinese Medicine, No.13 Wuhe Road, Nanning 530200, China.

Förderung

  • National Natural Science Foundation of China
  • Key Program of Science and Technology Department of Guangxi
  • Joint Fund of NSFC-Guangxi
  • Guangxi University of Chinese Medicine
  • High-level Talent of Guangxi Traditional Chinese Medicine
  • Wellcome Trust
  • General Project of Guangxi University of Chinese Medicine for the Construction of First-Class Disciplines in Guangxi
  • The Scientific Research Foundation of Institute of Marine Drugs

Zitieren

APA

Jiang, C., Feng, G., Wang, Z., Liu, K., Qu, X., Liu, Y., Yi, X., & Gao, C. (2024). Antifungal activity of bamemacrolactine C against Talaromyces marneffei and its possible mechanisms of action. Journal of Applied Microbiology. https://doi.org/10.1093/jambio/lxae297

Vancouver

Jiang C, Feng G, Wang Z, Liu K, Qu X, Liu Y, et al. Antifungal activity of bamemacrolactine C against Talaromyces marneffei and its possible mechanisms of action. Journal of Applied Microbiology. 2024. doi:10.1093/jambio/lxae297

BibTeX
@article{Jiang2024,
  author = {Jiang, Cuiping and Feng, Guangfu and Wang, Zhou and Liu, Kai and Qu, Xinjian and Liu, Yonghong and Yi, Xiangxi and Gao, Chenghai},
  title = {Antifungal activity of bamemacrolactine C against Talaromyces marneffei and its possible mechanisms of action},
  journal = {Journal of Applied Microbiology},
  year = {2024},
  doi = {10.1093/jambio/lxae297}
}
Kostenlos starten →